Mayo researcher to lead HHS Alzheimer's council

Ronald Petersen, MD, director of the Mayo Alzheimer’s Disease Research Center and the Mayo Clinic Study of Aging, was selected to chair the Advisory Council on Alzheimer’s Research, Care and Services. The formation of the group was announced Aug. 23 by the U.S. Department of Health and Human Services (HHS) Secretary Kathleen Sebelius.

The 12 non-federal council members include Alzheimer's disease patient advocates, caregivers and healthcare providers. They will advise the secretary on federal programs that impact people with Alzheimer’s disease and related dementia. Alzheimer’s disease affects 5.1 million people in the U.S. and is expected to impact more than 20 million people by 2050, according to a statement from Mayo, which is located in Rochester, Minn.

The advisory council will meet quarterly to help develop a nationwide plan involving HHS, the Department of Veterans Affairs, the Department of Defense and the National Science Foundation. The council is required by the National Alzheimer’s Project Act. Its members will serve four-year terms.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.